Uterine Microbiome

NewsGuard 100/100 Score

Interest in the microbiome of the reproductive tract has been growing over recent years. Studies of vaginal and placental microbiomes have shown associations between these microbiomes and obstetric outcomes and it is plausible that the uterine microbiome is also associated with these outcomes.

Since infection is a major cause of preterm birth, many studies over the last ten years have focused on identifying microorganisms residing in the uterus and recording any association with pregnancy outcome.

Current knowledge about the uterine microbiome has been greatly enhanced by the availability of molecular techniques in the field of microbiology, which has led to the discovery of various bacterial taxa that had not previously been described.

The bacteria present in the uterine cavity that so far seem to be the most strongly linked to negative outcomes in pregnancy are Ureaplasma sp. and Fusobacterium sp. Viruses are also present in the uterus, but they only seem to be significant contributors to preterm birth when they are present in combination with bacterial infection. Currently, researchers’ understanding of fungi colonizing the uterus is restricted to Candida species and further research is needed in this area.

The main pathway by which microbes have been thought to colonize the uterus is vertical ascension from the vagina, but research is beginning to suggest that microbes reach the uterus after they move from the mother’s mouth into the bloodstream when she cleans her teeth, for example. Some murine models have shown evidence of this route of microbial transfer, but further studies are needed to clarify this.

The uterine microbiome composition has also been explored as a contributory factor in the development of endometrial cancer. In a 2016 study, Nicholas Chia (Department of surgery, Mayo Clinic) and colleagues analyzed samples taken from the female reproductive tract (the vagina, cervix, ovaries and fallopian tubes) of patients who had endometrial cancer or hyperplasia and compared them with samples taken from patients with benign conditions of the uterus.

As reported in Genome Medicine, high throughput next generation DNA sequencing was used to identify the microbiota present, which showed that several taxa were significantly more abundant in the patients with endometrial cancer and hyperplasia compared with the patients who had benign conditions.

In particular, the presence of A. vaginae and Porphyromonas species, together with a high vaginal pH was significantly associated with the presence of endometrial cancer. The researchers say these microbes have previously been shown to be associated with other pathologies and that their results suggest a role of the microbiome in the cause and progression of this cancer that requires further research.


Further Reading

Last Updated: Feb 26, 2019

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2019, February 26). Uterine Microbiome. News-Medical. Retrieved on May 21, 2024 from https://www.news-medical.net/life-sciences/Uterine-Microbiome.aspx.

  • MLA

    Robertson, Sally. "Uterine Microbiome". News-Medical. 21 May 2024. <https://www.news-medical.net/life-sciences/Uterine-Microbiome.aspx>.

  • Chicago

    Robertson, Sally. "Uterine Microbiome". News-Medical. https://www.news-medical.net/life-sciences/Uterine-Microbiome.aspx. (accessed May 21, 2024).

  • Harvard

    Robertson, Sally. 2019. Uterine Microbiome. News-Medical, viewed 21 May 2024, https://www.news-medical.net/life-sciences/Uterine-Microbiome.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.